| Abstract: |
Having recently been present at the European Society for Sexual Medicine (ESSM) meeting in Lisbon, I was struck by two things. First, I was impressed with the variety of physician specialties represented there and how multidisciplinary sexual medicine has become. Second, it was interesting to me how little new and important information was presented on novel medical pharmacotherapy for sexual dysfunction, male and female. There is little doubt that the catapulting of sexual medicine, ISSM, and the Journal of Sexual Medicine (JSM) to their current statures was due at least in small part to the development of effective pharmacotherapy for erectile dysfunction (ED), the explosion of consumer interest and of research (clinical and basic) in sexual medicine. I have deduced that the future of sexual medicine, and therefore the ISSM and the JSM, is bright and shining. In our specialty, we have some of the most brilliant minds that exist in academic medicine, we have some of the most diligent clinicians, and I believe are ahead of other specialties that practice in a monodisciplinary fashion. (PsycINFO Database Record (c) 2010 APA, all rights reserved). |
